Hempfusion Wellness Inc. CBDHF

Company Overview

HempFusion Wellness Inc. is a health and wellness company focused on hemp-derived cannabidiol (CBD) products and complementary nutraceutical offerings. The company has operated within the broader consumer wellness, dietary supplement, and cannabinoid sectors, developing products marketed for sleep, stress support, pain management, and overall wellness. HempFusion historically generated revenue through retail distribution, direct-to-consumer e-commerce, and white-label or affiliated wellness channels. Its portfolio has included tinctures, capsules, topical products, gummies, and probiotic supplements under brands such as HempFusion, Probulin Probiotics, and Biome Research.

The company was founded in 2015 and pursued rapid expansion during the growth phase of the North American CBD market following evolving U.S. hemp regulations, including the 2018 Farm Bill. HempFusion became publicly traded in Canada and later quoted in U.S. over-the-counter markets under the ticker CBDHF. Public filings and market disclosures indicate the company sought differentiation through regulatory-focused manufacturing standards, physician and practitioner outreach, and broad retail placement across natural food, pharmacy, and wellness channels. Public disclosures from later periods also reflected financial pressures affecting the broader CBD industry, including pricing compression, regulatory uncertainty, and capital market constraints.